Last updated on August 2018
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: NIDDM | Diabetes Mellitus
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
- Type 1 or type 2 diabetic patients
- Performing auto-glycaemic control (at least 2 glycemias a day)
- Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump)
- Who have an Apple or Androde Smartphone compatible, or intend to acquire one before their participation in the study
- Whose HbA1c dating of less 1 month and more than 3 months is 8%
- Who are able to understand and follow the study protocol
- Who have given their signed consent to take part in the study
- Subject affiliated to the French National Health Insurance funds or benefiting from such insurance
Exclusion Criteria:
- Age < 18 years old
- Patients who have used the DIABEO system within 6 months before inclusion
- Participation in a clinical study within 6 months, except for the Meos (or tldiab 3) study after a participation period of 6 months
- Patients who are pregnant or who wish to become pregnant during the study.
- Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study.
